Granted Patent B2

US 12,518,875 · App. 18/001,923 · Granted Jan 6, 2026

Inventors: Farouc Amin Jaffer (Boston, MA); Guillermo Tearney (Boston, MA); Joseph Gardecki (Boston, MA); Mazen Albaghdadi (Boston, MA); Ryutaro Ikegami (Boston, MA); Mohamad Kassab (Boston, MA)

Assignee: The General Hospital Corporation

G16H50/20A61B5/0082G16H30/40G06T2207/30101

Abstract

Claims (67)

1 . A computer-implemented method for diagnosing a medical condition of a patient, the method comprising:

causing, using one or more processors, an excitation source to emit an excitation light towards a region of interest of an artery;

receiving, using the one or more processors and a detector, imaging data of the region of interest of the artery;

generating, using the one or more processors and the imaging data, at least one image of the region of interest;

separating, using the one or more processors, imaging data that comprises a risk region of an atheromatous plaque from imaging data that does not comprise a risk region for atheromatous plaque, based on an intensity threshold; and

determining a size, a shape, or an oxidative stress value for the risk region of an atheromatous plaque;

determining, using the one or more processors, that the size, shape, or oxidative stress value of the risk region of an atheromatous plaque is greater than a threshold size, a threshold shape, or a threshold oxidative stress; and

generating a report that includes information regarding the atheromatous plaque and that a threshold was exceeded.

2 . The method of claim 1 , further comprising:

determining, using the one or more processors, a maximum intensity value of the imaging data; and

determining, using the one or more processors, a threshold, based on the maximum intensity value, and

wherein a pixel with the maximum intensity value is defined within the risk region of the atheromatous plaque.

3 . The method of claim 1 , wherein the risk region of the atheromatous plaque has a higher amount of insoluble lipids than the region of the atheromatous plaque that does not include the risk region, and

wherein the risk region of the atheromatous plaque has a higher amount of insoluble iron than the region of the atheromatous plaque that does not include the risk region.

4 . The method of claim 1 , further comprising filtering, using the one or more processors, the image to generate an image of the risk region of the atheromatous plaque.

5 . The method of claim 4 , further comprising:

determining, using the one or more processors, a size of the risk region of the atheromatous plaque, based on the image of the risk region of the atheromatous plaque;

determining, using the one or more processors, that the size of the risk region is greater than a size threshold; and

determining, using the one or more processors, that the patient has a severe case of an atheromatous plaque, based on the size of the risk region being greater than the size threshold.

6 . The method of claim 4 , wherein filtering, using the one or more processors, the image to generate an image of the risk region of the atheromatous plaque includes:

thresholding, using the one or more processors, the image of the region of interest according to a pixel intensity threshold to generate the image of the risk region of the atheromatous plaque.

7 . The method of claim 6 , wherein the pixel intensity threshold rejects pixels having an intensity that exceeds the pixel intensity threshold, and

wherein the pixel intensity threshold is at least one of:

a first range defined between a peak signal intensity value in the imaging data and a first pixel value that is 0.25 times the peak intensity value;

a second range defined between the peak signal intensity value and a second pixel value that is 0.5 times the peak signal intensity value; or

a third range defined between the peak signal intensity value and a first pixel value that is 0.75 times the peak signal intensity value.

8 . The method of claim 7 , wherein the signal intensity peak value is a global peak signal intensity value.

9 . The method of claim 1 , wherein the image is a first image, and further comprising:

filtering, using the one or more processors, the first image to generate a second image of the atheromatous plaque that excludes the risk region; and

subtracting, using the one or more processors, the second image from the first image to generate a subtracted image that is an image of the risk region of the plaque.

10 . The method of claim 9 , wherein a portion of the risk region of the atheromatous plaque includes a ceroid of the atheromatous plaque.

11 . The method of claim 9 , wherein filtering, using the one or more processors, the first image to generate the second image of the atheromatous plaque that excludes the risk region includes thresholding the first image according to a threshold to generate the second image.

12 . The method of claim 1 , wherein no imaging agent is administered to the patient prior to exciting the region of interest with the excitation source, and prior to receiving the imaging data from the detector.

13 . The method of claim 1 , wherein the artery is a carotid artery.

14 . The method of claim 1 , further comprising:

determining, using the one or more processors, a shape of the atheromatous plaque; and

determining, using the one or more processors, that the shape of the atheromatous plaque exceeds a shape threshold; and

notifying, using the one or more processors, a user based on the shape of the risk region of the atheromatous plaque exceeding the shape threshold.

15 . The method of claim 1 , wherein the excitation light has a wavelength between 600 nm and 800 nm and the imaging data has been acquired from light having a wavelength of between 680 nm to 880 nm.

16 . The method of claim 1 , wherein the excitation light has a wavelength between substantially 600 nm and substantially 1000 nm.

17 . The method of claim 1 , wherein the excitation light has a wavelength of substantially 633 nm.

18 . An imaging system for imaging a blood vessel of a patient, the imaging system comprising:

an excitation source configured to emit excitation light towards the blood vessel of the patient;

a detector configured to sense light emitted from the blood vessel of the patient; and

a computing device in communication the excitation source and the detector, the computing device being configured to:

cause the excitation source to emit excitation light towards at least a portion of a region of interest of the blood vessel;

receive, using the detector, imaging data of the region of interest of the blood vessel;

generate, using the imaging data, at least one image of the region of interest;

separate imaging data that comprises a risk region of an atheromatous plaque from imaging data that does not comprise a risk region for atheromatous plaque based on an intensity threshold;

determine a size, a shape, or an oxidative stress value for the risk region of an atheromatous plaque;

determine that the size, shape, or oxidative stress value of the risk region of an atheromatous plaque is greater than a threshold size, a threshold shape, or a threshold oxidative stress; and

generate a report that includes information regarding the atheromatous plaque and that a threshold was exceeded.

19 . The imaging system of claim 18 , wherein the computing device is further configured to generate, using the imaging data, an image of the region of interest.

20 . The imaging system of claim 19 , wherein the computing device is further configured to:

threshold the image according to a pixel threshold to generate an image of a risk region of the atheromatous plaque;

determine at least one of a size or a shape of the risk region of the atheromatous plaque;

determine that at least one of the size of the atheromatous plaque exceeds a size threshold, or the shape of the atheromatous plaque exceeds a shape threshold; and

determine that the patient has a severe case of an atheromatous plaque, based on the determination that at least one of the size, or the shape of the atheromatous plaque exceeds the corresponding threshold.

21 . The imaging system of claim 19 , wherein the computing device is further configured to:

generate, an image of a non-risk region of the plaque; and

determine an oxidative stress value, based on the non-risk region of the plaque; and

determine that the patient has a severe case of the atheromatous plaque, based on the oxidative stress value.

22 . The imaging system of claim 21 , wherein the computing device is further configured to:

determine that the oxidative stress value exceeds an oxidative stress threshold; and

determine that the patient has a severe case of an atheromatous plaque, based on the determination that the oxidative stress value exceeds the oxidative stress threshold.

23 . The system of claim 18 , wherein the excitation light has a wavelength between substantially 600 nm and substantially 1000 nm.

24 . The system of claim 23 , wherein the excitation light has a wavelength of substantially 633 nm.

Continuity (3)

References Cited (18)